Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The association between body mass index and health-related quality of life in the 2017 and 2018 health survey of England data: A cross-sectional observational analysis.
Diabetes Obes Metab. 2024 Jun;26(6):2318-2328. doi: 10.1111/dom.15546. Epub 2024 Mar 18.
Diabetes Obes Metab. 2024.
PMID: 38499493
Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights.
Kral P, Allen FL, Larsen S, Holst-Hansen T, Olivieri AV, Manton A.
Kral P, et al. Among authors: holst hansen t.
Diabetes Obes Metab. 2024 Apr;26(4):1171-1179. doi: 10.1111/dom.15426. Epub 2024 Jan 9.
Diabetes Obes Metab. 2024.
PMID: 38195847
Item in Clipboard
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity.
Wilkinson L, Holst-Hansen T, Laursen PN, Rinnov AR, Batterham RL, Garvey WT.
Wilkinson L, et al. Among authors: holst hansen t.
Obesity (Silver Spring). 2023 Sep;31(9):2249-2259. doi: 10.1002/oby.23842.
Obesity (Silver Spring). 2023.
PMID: 37605636
Clinical Trial.
Item in Clipboard
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, Rubino DM, Garvey WT; OASIS 1 Investigators.
Knop FK, et al. Among authors: holst hansen t.
Lancet. 2023 Aug 26;402(10403):705-719. doi: 10.1016/S0140-6736(23)01185-6. Epub 2023 Jun 26.
Lancet. 2023.
PMID: 37385278
Clinical Trial.
Item in Clipboard
The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials.
Bjorner JB, Larsen S, Lübker C, Holst-Hansen T.
Bjorner JB, et al. Among authors: holst hansen t.
Diabetes Obes Metab. 2023 Aug;25(8):2142-2150. doi: 10.1111/dom.15090. Epub 2023 May 8.
Diabetes Obes Metab. 2023.
PMID: 37055712
Clinical Trial.
Item in Clipboard
Spatiotemporal NF-κB dynamics encodes the position, amplitude, and duration of local immune inputs.
Son M, Frank T, Holst-Hansen T, Wang AG, Junkin M, Kashaf SS, Trusina A, Tay S.
Son M, et al. Among authors: holst hansen t.
Sci Adv. 2022 Sep 2;8(35):eabn6240. doi: 10.1126/sciadv.abn6240. Epub 2022 Aug 31.
Sci Adv. 2022.
PMID: 36044569
Free PMC article.
Item in Clipboard
Impact of Zygosity on Bimodal Phenotype Distributions.
Holst-Hansen T, Abad E, Muntasell A, López-Botet M, Jensen MH, Trusina A, Garcia-Ojalvo J.
Holst-Hansen T, et al.
Biophys J. 2017 Jul 11;113(1):148-156. doi: 10.1016/j.bpj.2017.05.010.
Biophys J. 2017.
PMID: 28700913
Free PMC article.
Item in Clipboard
Cite
Cite